Despite Access to Antiretrovirals for Prevention and Treatment, High Rates of Mortality Persist among HIV-infected Infants and Young Children

listen audio

Study Justification:
This study aimed to investigate the mortality rates among HIV-infected infants and young children who have access to antiretroviral therapy (ART) for prevention and treatment. While the outcomes of HIV-infected children before widespread ART use have been well-documented, there is limited information on children who acquire HIV infection despite good ART access. Understanding the factors associated with mortality in this population is crucial for improving their health outcomes.
Study Highlights:
– The study enrolled 272 newly diagnosed HIV-infected children aged ≤24 months in Johannesburg, South Africa.
– Within 6 months of enrollment, 19.5% of the children died, and 26.8% were lost to follow-up.
– The probability of death by 6 months after enrollment was 23.5%, with a median age of death at 9.1 months.
– ART initiation was associated with a 71% reduction in the risk of death.
– Factors independently associated with mortality included low weight-for-age, low CD4 count, and identification during hospitalization.
– Maternal factors such as low CD4 count and lack of maternal ART were also associated with increased mortality risk.
– Exposure to maternal/infant antiretrovirals for prevention of mother-to-child transmission (PMTCT) was associated with reduced mortality risk.
Study Recommendations:
Based on the findings, the study recommends the following:
1. Innovative approaches are needed to rapidly diagnose and initiate ART in young children as early in life as possible.
2. Efforts should be made to improve access to ART for HIV-infected infants and young children.
3. Interventions should focus on improving nutrition and addressing weight-for-age deficits in this population.
4. Maternal ART should be encouraged and provided to reduce the risk of mortality in HIV-infected children.
Key Role Players:
1. Healthcare providers: Pediatricians, nurses, and other healthcare professionals involved in the care of HIV-infected infants and young children.
2. Policy makers: Government officials, policymakers, and organizations responsible for developing and implementing healthcare policies related to HIV/AIDS.
3. Researchers: Scientists and researchers specializing in pediatric HIV/AIDS and public health.
4. Community organizations: Non-governmental organizations (NGOs) and community-based organizations working to support HIV-infected children and their families.
Cost Items for Planning Recommendations:
1. Diagnostic tools and equipment for early HIV diagnosis in infants.
2. Antiretroviral drugs for treatment and prevention.
3. Training programs for healthcare providers on early diagnosis and initiation of ART.
4. Nutritional support programs to address weight-for-age deficits.
5. Maternal ART programs and services.
6. Awareness campaigns and educational materials for caregivers and communities.
7. Monitoring and evaluation systems to track the progress and impact of interventions.
Please note that the cost items provided are general categories and not actual cost estimates. The actual costs may vary depending on the specific context and implementation strategies.

Background: Outcomes of HIV-infected children before widespread use of antiretroviral therapy (ART) for treatment and prevention of mother-to-child transmission (PMTCT) have been well characterized but less is known about children who acquire HIV infection in the context of good ART access. Methods: We enrolled newly diagnosed HIV-infected children ≤24 months of age at 3 hospitals and 2 clinics in Johannesburg, South Africa. We report ART initiation and mortality rates during 6 months from enrollment and factors associated with mortality. Results: Of 272 children enrolled, median age 6.1 months, 69.5% were diagnosed during hospitalization. By 6 months postenrollment, 53 (19.5%) died and 73 (26.8%) were lost-to-follow-up. Using Kaplan-Meier analysis, the probability of death by 6 months after enrollment was 23.5%. The median age of death was 9.1 months [95% confidence interval (CI): 8.6-12.0]. Overall, 226 (83%) children initiated ART which was associated with a 71% reduction in risk of death [hazard ratio (HR) = 0.29 (95% CI: 0.15-0.58)]. In multivariable analysis of infant factors, weight-for-age Z score <-2 standard deviation (SD) [HR = 2.43 (95% CI: 1.03-5.73)], CD4 350/no maternal ART; exposure to maternal/infant antiretrovirals for PMTCT was associated with reduced mortality risk [HR = 0.53 (95% CI: 0.28-0.99)] versus no PMTCT. Conclusions: ART initiation is highly protective against death in young children. However, despite improved access to ART, young children remain at risk for early death; innovative approaches to rapidly diagnose and initiate treatment as early in life as possible are needed.

N/A

Based on the provided information, here are some potential innovations that could improve access to maternal health:

1. Early Diagnosis and Treatment: Develop innovative approaches to rapidly diagnose HIV infection in infants and young children, allowing for early initiation of antiretroviral therapy (ART) to improve health outcomes and reduce mortality rates.

2. Point-of-Care Testing: Implement point-of-care testing technologies that can accurately diagnose HIV infection in infants and young children at the healthcare facilities where they are being seen, enabling immediate initiation of treatment without delays caused by sending samples to external laboratories.

3. Integrated Care Models: Establish integrated care models that bring together maternal and child health services, ensuring that pregnant women living with HIV receive comprehensive care and support throughout the antenatal, intrapartum, and postnatal periods, as well as their infants.

4. Community-Based Approaches: Implement community-based approaches to reach pregnant women and mothers with HIV who may face barriers to accessing healthcare services, such as transportation or stigma. This could involve mobile clinics, community health workers, or telemedicine initiatives.

5. Health Information Systems: Strengthen health information systems to improve data collection, monitoring, and evaluation of maternal health programs. This can help identify gaps in care, track progress, and inform decision-making to ensure that interventions are effective and targeted.

6. Capacity Building: Invest in training and capacity building for healthcare providers, particularly in areas with high HIV prevalence, to ensure they have the knowledge and skills to provide quality maternal and child health services, including HIV testing, treatment, and counseling.

7. Behavioral Interventions: Develop innovative behavioral interventions to promote HIV testing and treatment adherence among pregnant women and mothers, addressing barriers such as fear, stigma, and misconceptions.

8. Public-Private Partnerships: Foster collaborations between public and private sectors to leverage resources, expertise, and technology to improve access to maternal health services, including HIV prevention, testing, and treatment.

These innovations aim to address the persistently high rates of mortality among HIV-infected infants and young children, despite access to antiretroviral therapy. By improving access to maternal health services and implementing innovative approaches, it is hoped that the health outcomes for both mothers and their children can be significantly improved.
AI Innovations Description
Recommendation: To improve access to maternal health and reduce mortality rates among HIV-infected infants and young children, the following innovation can be developed:

1. Early Infant Diagnosis and Treatment: Implement innovative approaches to rapidly diagnose HIV infection in infants and initiate antiretroviral therapy (ART) as early as possible. This can be achieved by strengthening and expanding existing early infant diagnosis programs, ensuring that all infants born to HIV-positive mothers are tested for HIV within the first few weeks of life. Additionally, healthcare providers should be trained on the latest diagnostic techniques and treatment protocols for HIV-infected infants.

2. Integrated Maternal and Child Health Services: Establish integrated maternal and child health services that provide comprehensive care for both HIV-positive mothers and their infants. This includes ensuring access to antenatal care, HIV testing and counseling, prevention of mother-to-child transmission (PMTCT) interventions, and postnatal care for both mother and child. By integrating these services, it becomes easier to identify and address the specific needs of HIV-infected infants and young children.

3. Community-based Approaches: Develop community-based programs that focus on raising awareness about maternal health, HIV prevention, and early infant diagnosis and treatment. These programs can include community health workers who provide education, counseling, and support to HIV-positive mothers and their families. By bringing healthcare services closer to the community, it becomes more accessible and convenient for mothers and their infants to receive the necessary care.

4. Strengthening Health Systems: Invest in strengthening health systems to ensure that healthcare facilities have the necessary infrastructure, equipment, and trained healthcare professionals to provide quality maternal and child health services. This includes improving laboratory capacity for early infant diagnosis, ensuring an adequate supply of antiretroviral drugs, and providing ongoing training and support to healthcare providers.

5. Research and Innovation: Encourage research and innovation in the field of maternal and child health to identify new approaches and technologies that can improve access to care and reduce mortality rates. This can include the development of point-of-care diagnostic tools, innovative treatment regimens, and strategies to improve adherence to ART among HIV-infected infants and young children.

By implementing these recommendations, it is possible to develop innovative solutions that can improve access to maternal health and reduce mortality rates among HIV-infected infants and young children.
AI Innovations Methodology
To improve access to maternal health and address the high rates of mortality among HIV-infected infants and young children, here are some potential recommendations:

1. Strengthening PMTCT Programs: Enhance and expand prevention of mother-to-child transmission (PMTCT) programs by ensuring universal access to antiretroviral therapy (ART) for pregnant women living with HIV. This includes providing comprehensive counseling, testing, and treatment services.

2. Early Infant Diagnosis (EID): Implement innovative approaches to rapidly diagnose HIV infection in infants, such as point-of-care testing or dried blood spot testing. This will enable early identification of HIV-infected infants and prompt initiation of ART.

3. Integrated Care: Integrate maternal and child health services with HIV care to ensure seamless and coordinated care for both the mother and the child. This can be achieved through the establishment of integrated clinics or through task-shifting to enable healthcare providers to deliver comprehensive care.

4. Community-Based Interventions: Implement community-based interventions to improve access to maternal health services, including HIV testing, counseling, and treatment. This can involve community health workers, mobile clinics, or outreach programs to reach remote or underserved populations.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could include the following steps:

1. Data Collection: Gather relevant data on the current state of access to maternal health services, including HIV testing, treatment, and PMTCT programs. This can involve reviewing existing literature, conducting surveys, or analyzing health facility data.

2. Modeling: Develop a mathematical or statistical model to simulate the impact of the recommendations on improving access to maternal health. This can involve estimating the number of additional pregnant women who would receive HIV testing, the number of infants who would be diagnosed early, and the potential reduction in mortality rates.

3. Assumptions and Parameters: Define the assumptions and parameters for the model, such as the coverage of the interventions, the effectiveness of the interventions, and the population size.

4. Sensitivity Analysis: Conduct sensitivity analysis to assess the robustness of the model and evaluate the impact of varying parameters or assumptions on the outcomes. This can help identify key drivers of the results and potential areas for improvement.

5. Evaluation and Policy Recommendations: Analyze the results of the simulation to evaluate the potential impact of the recommendations on improving access to maternal health. Based on the findings, provide policy recommendations for implementing the identified interventions and strategies.

It is important to note that the methodology described above is a general framework and the specific details may vary depending on the context and available data.

Partilhar isto:
Facebook
Twitter
LinkedIn
WhatsApp
Email